menu search

Belite Bio Reports Full-Year 2022 Operational Highlights and Financial Results

Belite Bio Reports Full-Year 2022 Operational Highlights and Financial Results
12-month interim data from the ongoing 2-year, Phase 2 Stargardt disease (STGD1) study continues to show halting or slowing of lesion growth; 18-month efficacy and safety update expected during the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting on April 25 42 subjects have been enrolled for the pivotal Phase 3 “DRAGON” […] The post Belite Bio Reports Full-Year 2022 Operational Highlights and Financial Results appeared first on ForexTV... Read More
Posted: Mar 31 2023, 23:03
Author Name: forextv
Views: 102445

Search within

Pages Search Results: